DrugId:  1
1. Name:  GW-406381
2. Groups:  Investigational
3. Description:  GW-406381 has been used in trials studying the treatment of Pain, Trauma, Neurodynia, Dental Pain, and Hyperalgesia, among others.
4. Indication:  Not Available
DrugId:  2
1. Name:  Gabapentin Enacarbil
2. Groups:  Approved, Investigational
3. Description:  Gabapentin enacarbil is marketed under the name Horizant. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
4. Indication:  For the treatment of adult Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
DrugId:  3
1. Name:  Ethopropazine
2. Groups:  Approved
3. Description:  Ethopropazine (also known as profenamine hydrochloride) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.
4. Indication:  For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.
DrugId:  4
1. Name:  AV608
2. Groups:  Investigational
3. Description:  AV608 is a NK-1 antagonist. It is developed for the treatment of Social anxiety disorder (SAD), irritable bowel syndrome (IBS) and overactive bladder (OAB).
4. Indication:  Investigated for use/treatment in anxiety disorders, irritable bowel syndrome (IBS), and urinary incontinence.
DrugId:  5
1. Name:  Bupivacaine
2. Groups:  Approved, Investigational
3. Description:  A widely used local anesthetic agent. [PubChem]
4. Indication:  For the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.
